1. Home
  2. CET vs PAHC Comparison

CET vs PAHC Comparison

Compare CET & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CET

Central Securities Corporation

N/A

Current Price

$56.69

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

N/A

Current Price

$34.92

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CET
PAHC
Founded
1929
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CET
PAHC
Price
$56.69
$34.92
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $47.00
AVG Volume (30 Days)
30.2K
★ 191.7K
Earning Date
01-01-0001
11-04-2026
Dividend Yield
★ 4.90%
1.46%
EPS Growth
N/A
★ 104.20
EPS
N/A
★ 0.72
Revenue
N/A
★ $833,350,000.00
Revenue This Year
N/A
$4.08
Revenue Next Year
N/A
$3.43
P/E Ratio
★ $6.93
$46.35
Revenue Growth
N/A
★ 4.12
52 Week Low
$47.82
$28.25
52 Week High
$57.39
$60.08

Technical Indicators

Market Signals
Indicator
CET
PAHC
Relative Strength Index (RSI) 55.18 41.15
Support Level $54.66 $32.97
Resistance Level $57.17 $40.69
Average True Range (ATR) 1.12 1.68
MACD -0.03 -0.60
Stochastic Oscillator 80.00 23.72

Price Performance

Historical Comparison
CET
PAHC

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: